Cardiff Oncology, Inc. (CRDF) Q1 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Cardiff Oncology, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.476 Welcome to the Cardios of Oncology first quarter 2024 financial results 00:00:05.476 -- 00:00:10.361 and business update conference call. At this time, all participants are in a listen-only 00:00:10.361 -- 00:00:15.666 mode. After the speaker's presentation, there will be a question and answer session. 00:00:15.666 -- 00:00:21.552 To ask a question during the session, you will need to press star 11 on your telephone, 00:00:21.552 -- 00:00:26.397 and you will hear an automated message advising your hand is raised. 00:00:26.397 -- 00:00:29.815 Please be advised that today's conference is being recorded. 00:00:29.815 -- 00:00:34.599 I would now like to turn the conference over to Kiki Patel of Gilmartian Group. 00:00:34.599 -- 00:00:37.240 Please go ahead. 00:00:37.462 -- 00:00:42.347 Thank you, Operator. Joining us on the call today from Cardiff Oncology are Chief Executive 00:00:42.347 -- 00:00:46.651 Officer Mark Erlander and Chief Financial Officer Jamie Levine. 00:00:46.651 -- 00:00:50.815 During this conference call, management will make forward-looking statements, including, 00:00:50.815 -- 00:00:55.879 without limitation, statements related to guidance, results, and the timing of data readouts 00:00:55.879 -- 00:01:00.848 for unadvantaged clinical trials. These forward-looking statements are based on the company's 00:01:00.848 -- 00:01:05.673 current expectations and inherently involve significant risks and uncertainties. 00:01:05.673 -- 00:01:10.338 Our actual results and the timing of events could differ materially from those anticipated 00:01:10.338 -- 00:01:14.562 in such forward-looking statements as a result of these risks and uncertainties. 00:01:14.562 -- 00:01:18.246 Factors that could cause results to be different fr...